# EDGAR Filing Document

**Accession Number:** 0001142750
**File Stem:** 0001628280-26-029877
**Filing Date:** 2026-5
**Character Count:** 10557
**Document Hash:** 00341063e090adc166c1c99cf8699f95
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-029877.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0001628280-26-029877

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260501

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** HARRIS R JEFFREY
- **CENTRAL INDEX KEY:** 0001183645

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16753
- **FILM NUMBER:** 26938449

**MAIL ADDRESS:**
- **STREET 1:** 20735 BARTLETT DRIVE
- **CITY:** BROOKFIELD
- **STATE:** WI
- **ZIP:** 53045
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMN HEALTHCARE SERVICES INC
- **CENTRAL INDEX KEY:** 0001142750
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 061500476
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2999 OLYMPUS BOULEVARD
- **STREET 2:** SUITE 500
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019
- **BUSINESS PHONE:** 8668718519

**MAIL ADDRESS:**
- **STREET 1:** 2999 OLYMPUS BOULEVARD
- **STREET 2:** SUITE 500
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>HARRIS R JEFFREY<br><sub>(Last) (First) (Middle)</sub><br>2999 OLYMPUS BOULEVARD<br>SUITE 500<br><sub>(Street)</sub><br>DALLAS, TX 75019<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-05-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>AMN HEALTHCARE SERVICES INC [ AMN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-05-01 |  | M<sup>(1)</sup> |  | 8325 | A | $0 | 67262 | D |  |
| Common Stock | 2026-05-01 |  | M<sup>(1)</sup> |  | 5555 | A | $0 | 72817 | D |  |
| Common Stock | 2026-05-01 |  | M<sup>(1)</sup> |  | 4048 | A | $0 | 76865 | D |  |
| Common Stock | 2026-05-01 |  | M<sup>(1)</sup> |  | 6009 | A | $0 | 82874 | D |  |
| Common Stock | 2026-05-01 |  | M<sup>(1)</sup> |  | 9563 | A | $0 | 92437 | D |  |
| Common Stock | 2026-05-01 |  | M<sup>(1)</sup> |  | 9563 | A | $0 | 102000 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(2)</sup> | 2026-05-01 |  | M |  |  | 8325 | <sup>(3)</sup> | <sup>(4)</sup> | Common Stock | 8325 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2026-05-01 |  | M |  |  | 5555 | <sup>(6)</sup> | <sup>(4)</sup> | Common Stock | 5555 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2026-05-01 |  | M |  |  | 4048 | <sup>(7)</sup> | <sup>(4)</sup> | Common Stock | 4048 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2026-05-01 |  | M |  |  | 6009 | <sup>(8)</sup> | <sup>(4)</sup> | Common Stock | 6009 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2026-05-01 |  | M |  |  | 9563 | <sup>(9)</sup> | <sup>(4)</sup> | Common Stock | 9563 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2026-05-01 |  | M |  |  | 9563 | <sup>(10)</sup> | <sup>(4)</sup> | Common Stock | 9563 | $0 | 0 | D |  |

---

### Footnotes:

(1) AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

(2) The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

(3) The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

(4) RSUs do not have an expiration date.

(5) The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

(6) The Restricted Stock Units were granted on April 12, 2006 and vest in the incremental amount of 33% on the earlier of (i) April 12, 2007 and (ii) the date of the Company's 2007 Annual Meeting of Stockholders; 34% on the earlier of (ii) April 12, 2008 and (ii) the date of the Company's 2008 Annual Meeting of Stockholders; and 33% on April 12, 2009.  At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company.

(7) The Restricted Stock Units were granted on April 18, 2007 and vest in the incremental amount of 33% on the earlier of (i) April 18, 2008 or (ii) the date of the Company's 2008 Annual Meeting of Stockholders; 34% on the earlier of (i) April 18, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 18, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders.  At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company.

(8) The Restricted Stock Units were granted on April 8, 2008 and vest in the incremental amount of 33% on the earlier of (i) April 8, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders; 34% on the earlier of (i) April 8, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 8, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders.  At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company.

(9) The Restricted Stock Units were granted on April 9, 2009 and vest in the incremental amount of 33% on the earlier of (i) April 9, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders; 34% on the earlier of (i) April 9, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 9, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders.  At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company.

(10) The Restricted Stock Units were granted on April 13, 2010 and vest in the incremental amount of 33% on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; 34% on the earlier of (i) April 13, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 13, 2013 or (ii) the date of the Company's 2013 Annual Meeting of Stockholders.  At the reporting owner's irrevocable election, the number of RSUs identified in this row settled on May 1, 2026, the date of the director's separation from service with the company.

**Signature:** /s/ Whitney M. Laughlin, as attorney-in-fact on behalf of R. Jeffrey Harris  
**Date:** 2026-05-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**